Patent Medical hosts Vienna symposium on Symbionic Teeth and peri-implantitis
Corporate symposium at Osteology Vienna on 23 April discussing new implant design addressing peri-implantitis prevention.
Patent Medical will host a free corporate symposium on Symbionic Teeth during the International Osteology Symposium in Vienna on 23 April at 5 p.m. CEST. The session will feature implantology experts Prof. Anton Sculean and Dr Roland Glauser discussing the Swiss company's tooth replacement concept designed to prevent peri-implant complications.
How Symbionic Teeth address peri-implant disease
Natural teeth are protected by a soft-tissue defence barrier that limits plaque migration and bacterial invasion. When a tooth is lost, this protective barrier is also lost. The Symbionic Teeth concept aims to restore this protection by forming a mucosal defence barrier around the implant. A meta-analysis has reported that peri-implant mucositis affects 43% of implant patients and peri-implantitis affects 22%, making these complications common in implant therapy.
What the symposium will cover
The session, titled "Symbionic teeth—next-generation tooth replacement with a mucosal defense barrier to effectively prevent peri-implantitis", will present scientific evidence on the mucosal defence barrier around Symbionic Teeth. Speakers will discuss treatment outcomes including soft-tissue health, peri-implantitis prevention and aesthetic stability over time. No separate registration is required for attendees of the International Osteology Symposium.
Frequently asked questions
When is the Symbionic Teeth symposium in Vienna?
The free corporate symposium takes place on 23 April 2026 at 5 p.m. CEST in Auditorium 2 at Messe Wien. No separate registration is required for attendees of the International Osteology Symposium.
What is the Symbionic Teeth concept?
Symbionic Teeth is a tooth replacement concept designed to restore the soft-tissue defence barrier that natural teeth possess. This mucosal defence barrier limits plaque migration and bacterial invasion, addressing common biological complications associated with implant therapy.
What are the prevalence rates of peri-implant disease?
According to a meta-analysis cited in the article, peri-implant mucositis has a prevalence rate of 43% and peri-implantitis has a prevalence rate of 22% among implant patients.
Who are the speakers at the Symbionic Teeth symposium?
The session will feature Prof. Anton Sculean and Dr Roland Glauser, both implantology experts who will discuss scientific evidence and treatment outcomes associated with the Symbionic Teeth concept.
